Journal of Medical Virology · 1987 · 58 citations · 9 references
PharmacyInfectious DiseasesPharmacotherapyPediatric Infectious DiseasesPediatric PharmacotherapyVirologyAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyInfluenza Antiviral ResistanceInfluenza Antiviral TherapyInfluenza TreatmentPediatric Antiviral PharmacologyPediatric Antiviral TherapyPediatric Infectious Diseases ManagementPediatric Viral InfectionsTherapeutic Trial Design
Rimantadine was compared with acetaminophen in a double-blind randomly assigned therapeutic trial in 63 children presenting with influenzal symptoms. Forty-nine of the children were proven to have influenza A by culture on presentation. Forty-three of the cultures, 88%, were influenza A/H1N1 strains. Both drugs were well tolerated. Rimantadine lowered the amount of virus shed in the first 2 days after initiation of therapy. Clinical resolution of illness was not different between the two therapeutic modalities. In individuals who shed virus for 4 days, strains recovered on the last day were relatively resistant to rimantadine.
9
Canine kidney cell line for isolation of respiratory viruses
H Meguro, J D Bryant, Anne E Torrence et al. · Journal of Clinical Microbiology · 1979 · 132 citations · Full text